All news

Bristol Myers Squibb Company $BMY Shares Sold by AIA Group Ltd

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

AIA Group Ltd significantly reduced its stake in Bristol Myers Squibb by 20.6% in the third quarter, selling over 30,000 shares. Despite this, other institutional investors increased their positions in the biopharmaceutical company, which recently reported strong quarterly earnings of

Read original source

BMY company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.